-
Pharmacological activation of Rev-erbα Provides Neuroprotection against Parkinson’s Disease
-
Phase 2 study evaluating safety, PK/PD, biomarkers, and efficacy of ANX005 in patients with Huntington’s disease (HD)
-
Phase-amplitude coupling between beta power and high frequency oscillations as a sensitive marker of parkinsonian state.
-
PHENOTYPIC DESCRIPTION OF TWO UNREPORTED FAMILIES WITH ANO3 DYSTONIA
-
Phenotypical and treatment response heterogeneity in a cohort of normal pressure hydrocephalus patients
-
Phosphorylated α-synuclein at serine residue 129 decreased in Parkinson’s disease patients taking 250mg of daily niacin for six months
-
Physical activity and incidence of Parkinson’s disease in French women from the E3N cohort study
-
Physician satisfaction from continuous telemonitoring in Parkinson’s disease
-
Pilot case on the use of transcranial pulsed current stimulation(tPCS) in a patient with cervical dystonia(CD)
-
Pilot study of narrative medicine (NM) interventions in facilitating advance care planning (ACP) in Parkinson’s disease (PD): a feasibility study
- « Previous Page
- 1
- …
- 107
- 108
- 109
- 110
- 111
- …
- 153
- Next Page »